OxSAT 100— 510(k) K191574

Substantially Equivalent

S.L.P. , Ltd.

FDA 510(k) clearance K191574 for OxSAT 100, Substantially Equivalent on 2020-04-09. Applicant: S.L.P. , Ltd..

Clearance details

Applicant: S.L.P. , Ltd.
Product code: Code DQA
Advisory panel: Cardiovascular
Date received: 2019-06-14
Decision date: 2020-04-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tel-Aviv, IL

Download summary PDF View on FDA.gov ↗

Adverse events under product code DQA

product code DQA

Death: 66
Malfunction: 2,867
Other: 1
Total: 2,934

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.